The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
Open accessAbstract
BACKGROUND Global genetic diversity of HIV-1 is a major challenge to the development of HIV vaccines. We aimed to estimate the regional and global distribution of HIV-1 subtypes and recombinants during 1990-2015. METHODS We searched PubMed, EMBASE (Ovid), CINAHL (Ebscohost), and Global Health (Ovid) for HIV-1 subtyping studies published between Jan 1, 1990, and Dec 31, 2015. We collected additional unpublished HIV-1 subtyping data through a global survey. We included prevalence studies with HIV-1 subtyping data collected during 1990-2015. We grouped countries into 14 regions and analysed data for four time periods (1990-99, 2000-04, 2005-09, and 2010-15). The distribution of HIV-1 subtypes, circulating recombinant forms (CRFs), and unique recombinant forms (URFs) in individual countries was weighted according to the UNAIDS estimates of the number of people living with HIV (PLHIV) in each country to generate regional and global estimates of HIV-1 diversity in each time period. The primary outcome was the number of samples designated as HIV-1 subtypes A, B, C, D, F, G, H, J, K, CRFs, and URFs. The systematic review is registered with PROSPERO, number CRD42017067164. FINDINGS This systematic review and global survey yielded 2203 datasets with 383 519 samples from 116 countries in 1990-2015. Globally, subtype C accounted for 46·6% (16 280 897/34 921 639 of PLHIV) of all HIV-1 infections in 2010-15. Subtype B was responsible for 12·1% (4 235 299/34 921 639) of infections, followed by subtype A (10·3%; 3 587 003/34 921 639), CRF02_AG (7·7%; 2 705 110/34 921 639), CRF01_AE (5·3%; 1 840 982/34 921 639), subtype G (4·6%; 1 591 276/34 921 639), and subtype D (2·7%; 926 255/34 921 639). Subtypes F, H, J, and K combined accounted for 0·9% (311 332/34 921 639) of infections. Other CRFs accounted for 3·7% (1 309 082/34 921 639), bringing the proportion of all CRFs to 16·7% (5 844 113/34 921 639). URFs constituted 6·1% (2 134 405/34 921 639), resulting in recombinants accounting for 22·8% (7 978 517/34 921 639) of all global HIV-1 infections. The distribution of HIV-1 subtypes and recombinants changed over time in countries, regions, and globally. At a global level during 2005-15, subtype B increased, subtypes A and D were stable, and subtypes C and G and CRF02_AG decreased. CRF01_AE, other CRFs, and URFs increased, leading to a consistent increase in the global proportion of recombinants over time. INTERPRETATION Global and regional HIV diversity is complex and evolving, and is a major challenge to HIV vaccine development. Surveillance of the global molecular epidemiology of HIV-1 remains crucial for the design, testing, and implementation of HIV vaccines. FUNDING None.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
Self-citationRobertson, D. L., Anderson, J. P., Bradac, J. A., Carr, J. K., Foley, B., Funkhouser, R. K., Gao, F., Hahn, B. H., Kalish, M. L., Kuiken, C., et al. (2000) · Science · doi:10.1126/science.288.5463.55d · Cited by 964
Self-citationDiversity Considerations in HIV-1 Vaccine Selection
Gaschen, B., Taylor, J., Yusim, K., Foley, B., Gao, F., Lang, D., Novitsky, V., Haynes, B., Hahn, B. H., Bhattacharya, T., et al. (2002) · Science · doi:10.1126/science.1070441 · Cited by 811
Self-citationThe early spread and epidemic ignition of HIV-1 in human populations
Faria, N. R., Rambaut, A., Suchard, M. A., Baele, G., Bedford, T., Ward, M. J., Tatem, A. J., Sousa, J. D., Arinaminpathy, N., Pépin, J., et al. (2014) · Science · doi:10.1126/science.1256739 · Cited by 736
Self-citationGlobal trends in molecular epidemiology of HIV-1 during 2000–2007
Hemelaar, J., Gouws, E., Ghys, P. D., & Osmanov, S. (2011) · AIDS · doi:10.1097/qad.0b013e328342ff93 · Cited by 692
Self-citationThe Challenge of HIV-1 Subtype Diversity
Taylor, B. S., Sobieszczyk, M. E., McCutchan, F. E., & Hammer, S. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706737 · Cited by 635
Self-citationGlobal and regional distribution of HIV-1 genetic subtypes and recombinants in 2004
Hemelaar, J., Gouws, E., Ghys, P. D., & Osmanov, S. (2006) · AIDS · doi:10.1097/01.aids.0000247564.73009.bc · Cited by 629
Self-citationEvolutionary and immunological implications of contemporary HIV-1 variation
Korber, B., Gaschen, B., Yusim, K., Thakallapally, R., Kesmir, C., & Detours, V. (2001) · British Medical Bulletin · doi:10.1093/bmb/58.1.19 · Cited by 540
The origin and diversity of the HIV-1 pandemic
Hemelaar, J. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.12.001 · Cited by 427
Self-citationBarouch, D. H., Tomaka, F. L., Wegmann, F., Stieh, D. J., Alter, G., Robb, M. L., Michael, N. L., Peter, L., Nkolola, J. P., Borducchi, E. N., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31364-3 · Cited by 336
Cited by
Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection
Orkin, C., Arasteh, K., Górgolas Hernández-Mora, M., Pokrovsky, V., Overton, E. T., Girard, P.-M., Oka, S., Walmsley, S., Bettacchi, C., Brinson, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1909512 · Cited by 487
Troyano-Hernáez, P., Reinosa, R., & Holguín, Á. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.854974 · Cited by 48
Self-citationByun, H., Papathanasopoulos, M. A., Steegen, K., & Basson, A. E. (2024) · Viruses · doi:10.3390/v16121888 · Cited by 5
Metadata
- Authors
- Hemelaar, J., Elangovan, R., Yun, J., Dickson-Tetteh, L., Fleminger, I., Kirtley, S., Williams, B., Gouws-Williams, E., Ghys, P. D., Abimiku, A. G., Agwale, S., Archibald, C., Avidor, B., Barbás, M. G., Barre-Sinoussi, F., Barugahare, B., Belabbes, E. H., Bertagnolio, S., Birx, D., Bobkov, A. F., Brandful, J., Bredell, H., Brennan, C. A., Brooks, J., Bruckova, M., Buonaguro, L., Buonaguro, F., Buttò, S., Buve, A., Campbell, M., Carr, J., Carrera, A., Carrillo, M. G., Celum, C., Chaplin, B., Charles, M., Chatzidimitriou, D., Chen, Z., Chijiwa, K., Cooper, D., Cunningham, P., Dagnra, A., de Gascun, C. F., Del Amo, J., Delgado, E., Dietrich, U., Dwyer, D., Ellenberger, D., Ensoli, B., Essex, M., Gao, F., Fleury, H., Fonjungo, P. N., Foulongne, V., Gadkari, D. A., García, F., Garsia, R., Gershy-Damet, G. M., Glynn, J. R., Goodall, R., Grossman, Z., Lindenmeyer-Guimarães, M., Hahn, B., Hamers, R. L., Hamouda, O., Handema, R., He, X., Herbeck, J., Ho, D. D., Holguin, A., Hosseinipour, M., Hunt, G., Ito, M., Bel Hadj Kacem, M. A., Kahle, E., Kaleebu, P. K., Kalish, M., Kamarulzaman, A., Kang, C., Kanki, P., Karamov, E., Karasi, J.-C., Kayitenkore, K., Kelleher, T., Kitayaporn, D., Kostrikis, L. G., Kucherer, C., Lara, C., Leitner, T., Liitsola, K., Lingappa, J., Linka, M., Lorenzana de Rivera, I., Lukashov, V., Maayan, S., Mayr, L., McCutchan, F., Meda, N., Menu, E., Mhalu, F., Mloka, D., Mokili, J. L., Montes, B., Mor, O., Morgado, M., Mosha, F., Moussi, A., Mullins, J., Najera, R., Nasr, M., Ndembi, N., Neilson, J. R., Nerurkar, V. R., Neuhann, F., Nolte, C., Novitsky, V., Nyambi, P., Ofner, M., Paladin, F. J., Papa, A., Pape, J., Parkin, N., Parry, C., Peeters, M., Pelletier, A., Pérez-Álvarez, L., Pillay, D., Pinto, A., Quang, T. D., Rademeyer, C., Raikanikoda, F., Rayfield, M. A., Reynes, J.-M., Rinke de Wit, T., Robbins, K. E., Rolland, M., Rousseau, C., Salazar-Gonzales, J., Salem, H., Salminen, M., Salomon, H., Sandstrom, P., Santiago, M. L., Sarr, A. D., Schroeder, B., Segondy, M., Selhorst, P., Sempala, S., Servais, J., Shaik, A., Shao, Y., Slim, A., Soares, M. A., Songok, E., Stewart, D., Stokes, J., Subbarao, S., Sutthent, R., Takehisa, J., Tanuri, A., Tee, K. K., Thapa, K., Thomson, M., Tran, T., Urassa, W., Ushijima, H., van de Perre, P., van der Groen, G., van Laethem, K., van Oosterhout, J., van Sighem, A., van Wijngaerden, E., Vandamme, A.-M., Vercauteren, J., Vidal, N., Wallace, L., Williamson, C., Wolday, D., Xu, J., Yang, C., Zhang, L., & Zhang, R.
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 19
- Issue
- 2
- Pages
- 143-155
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W2903314774
- Cited by
- 405
- References
- 21
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis. https://app.cochat.ai/papers/10.1016/s1473-3099(18)30647-9
- The paper
- Hemelaar, J., Elangovan, R., Yun, J., Dickson-Tetteh, L., Fleminger, I., Kirtley, S., Williams, B., Gouws-Williams, E., Ghys, P. D., Abimiku, A. G., Agwale, S., Archibald, C., Avidor, B., Barbás, M. G., Barre-Sinoussi, F., Barugahare, B., Belabbes, E. H., Bertagnolio, S., Birx, D., . . . Zhang, R. (2019). Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(18)30647-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.